U.S. court to hear Merck appeal on Vioxx investor suit
The U.S. Supreme Court said on Tuesday that it would hear an appeal by Merck & Co Inc of a ruling that reinstated a securities fraud lawsuit involving the company’s disclosures to investors about its withdrawn Vioxx pain drug.
Link to original article
Firm's Vioxx probe clears Merck
NEW YORK -- Merck & Co.'s board said yesterday that a 20-month investigation funded by the pharmaceutical company found senior management acted responsibly in their development and marketing of the now withdrawn pain reliever Vioxx.
Click here for more info
Jury Deliberating in Federal Vioxx Trial
Jury deliberations began Wednesday in the second federal lawsuit accusing drug manufacturer Merck & Co. of harming patients through deliberately hiding the dangers of its once-popular painkiller Vioxx
Click here for more info
Federal judges discuss Vioxx lawsuits (WBBH)
LEE COUNTY — Hundreds of people have filed suit against pharmaceutical giant Merck & Co., the makers of the drug Vioxx.
More...